Investors reacted negatively to Donald Trump’s nomination of vaccine skeptic Robert F Kennedy Jr as the top US health official, causing shares in vaccine makers and pharmaceutical companies to plummet. Kennedy’s controversial views on vaccines and plans to downsize the FDA led to concerns within the industry, impacting stocks across the pharmaceutical sector. Despite the sell-off, some experts believe that Kennedy’s extreme ideas may not become policy, with other cabinet appointees advocating for reducing barriers to drug approval.
Full Article
Amazon isn't slowing down on AI with a $10 billion data center in North Carolina
Amazon's Investment in AI InfrastructureAmazon (AMZN) is significantly increasing its investment in North Carolina, committing $10 billion to enhance AI infrastructure for Amazon Web Services’ data center supply chain. This decision is driven by the rising demand for compute power linked to generative AI technologies. The investment reflects Amazon's strategy to strengthen its position in the evolving AI landscape. Full Article
Read more